pseudotumor cerebri: Idiopathic intracranial hypertension is a neurological disorder characterized by isolated increased intracranial pressure manifesting with recurrent and persistent headaches, nausea, vomiting, progressive and transient obstruction of the visual field, papilledema. Visual loss can be irreversible.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
358 |
4. Check minimum number of eventsNone |
358 |
5. Include endpointsNone |
358 |
6. Filter based on genotype QC (FinnGen only) |
358 |
Control definitions (FinnGen only)
- Control exclude
- G6_OTHNEU
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G93
- Name in latin
- Hypertensio intracranialis benigna
Similar endpoints
↥List of similar endpoints to
Benign intracranial hypertension
based on the number of shared cases.
Similar with more cases:
- Other neurological diseases
- Neurological diseases
- Neurological diseases, wide definition
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1710 | 1314 | 380 |
| Only index persons | 1612 | 1273 | 339 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.04 | 0.01 |
| Only index persons | 0.04 | 0.05 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 31.63 | 30.53 | 35.22 |
| Only index persons | 31.49 | 30.53 | 35.08 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 358 | 300 | 58 |
| Unadjusted period prevalence (%) | 0.09 | 0.10 | 0.03 |
| Median age at first event (years) | 34.03 | 32.91 | 39.84 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 328
- Matched controls
- 3280
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G93.2
ICD-10 Finland
Benign intracranial hypertension
+∞
323.0
317
*
S01EC01
ATC
acetazolamide; systemic
842.4
265.8
228
9
H47.1
ICD-10 Finland
Papilloedema, unspecified
953.6
173.3
155
*
TAB00
NOMESCO Finland
Lumbar puncture
52.1
120.9
145
49
Z01.0
ICD-10 Finland
Examination of eyes and vision
16.7
98.3
181
225
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
23.6
71.8
106
65
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
27.9
71.0
99
50
XCK00
NOMESCO Finland
Perimetry
23.9
68.2
100
59
R51.80
ICD-10 Finland
Headache
9.5
68.2
172
340
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
14.0
60.9
112
117
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
44.1
57.0
70
20
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
60.8
55.4
64
13
XCW99
NOMESCO Finland
Other investigative procedure of eye
11.8
48.3
95
109
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
+∞
44.8
42
*
CS494
NOMESCO Finland
Other visual field testing
52.1
41.4
49
11
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
57.7
38.7
45
9
AA1AD
NOMESCO Finland
CT of head and brain
6.1
34.2
106
237
E66.01
ICD-10 Finland
Obesity due to excess calories
6.9
32.2
88
165
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
8.3
31.0
73
109
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
50.3
30.3
36
8
N03AX11
ATC
topiramate; oral
13.8
29.7
52
44
XCK10
NOMESCO Finland
Photography of fundus of eye
9.7
28.4
60
74
H53.1
ICD-10 Finland
Subjective visual disturbances
9.8
27.2
57
69
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
15.2
26.9
45
34
C03CA01
ATC
furosemide; systemic
6.3
26.0
75
148
E66.8
ICD-10 Finland
Other obesity
7.9
25.5
61
92
CK2A4
NOMESCO Finland
Autofluorescence imaging of ocular fundus
111.8
19.8
21
*
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
+∞
17.9
17
*
H47.3
ICD-10 Finland
Other disorders of optic disc
178.7
16.7
17
*
G44.2
ICD-10 Finland
Tension-type headache
3.5
15.8
84
295
A02BC02
ATC
pantoprazole; systemic
2.6
15.5
207
1298
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.9
15.2
52
122
CS3P4
NOMESCO Finland
Optic nerve head stereophotography
26.5
14.9
20
8
G47.3
ICD-10 Finland
Sleep apnoea
3.7
14.7
69
218
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
+∞
14.7
14
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
5.4
14.4
44
91
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
6.6
13.9
36
60
XCD10
NOMESCO Finland
Electrophysiological examination of eye
14.4
13.9
23
17
R42
ICD-10 Finland
Dizziness and giddiness
3.3
13.8
77
278
AAF10
NOMESCO Finland
Lumboperitoneal shunt
+∞
13.6
13
*
N02BE01
ATC
paracetamol; systemic, rectal
3.1
13.4
284
2217
H02AB06
ATC
prednisolone; systemic
2.4
13.0
156
892
E66.9
ICD-10 Finland
Obesity, unspecified
6.1
12.8
35
63
H53.4
ICD-10 Finland
Visual field defects
21.1
12.6
18
9
3482A
ICD-9 Finland
Other conditions of brain, Benign intracranial hypertension
+∞
12.6
12
*
G93.0
ICD-10 Finland
Cerebral cysts
+∞
12.6
12
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
12.3
117
587
N02AX02
ATC
tramadol; systemic, rectal
2.5
12.2
120
610
H53.9
ICD-10 Finland
Visual disturbance, unspecified
11.1
12.0
22
21
R4190
NOMESCO Finland
Nutritional therapy
7.0
11.9
29
45
H47.0
ICD-10 Finland
Disorders of optic nerve, not elsewhere classified
67.4
11.7
13
*
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
+∞
11.5
11
*
E23.06
ICD-10 Finland
Empty sella
124.2
11.5
12
*
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
3.5
11.4
55
177
T82
ICPC
Obesity
6.0
11.4
31
56
I10
ICD-10 Finland
Essential (primary) hypertension
2.5
11.1
103
506
H57.1
ICD-10 Finland
Ocular pain
8.4
10.8
23
29
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
9.0
10.7
22
26
N03AX16
ATC
pregabalin; oral
2.8
10.6
74
308
N03AX12
ATC
gabapentin; oral
3.2
10.4
58
207
R03AC02
ATC
salbutamol; inhalant
2.1
9.9
194
1331
A10BA02
ATC
metformin; oral
3.0
9.8
60
229
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
2.4
9.5
89
434
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
+∞
9.4
9
*
ZXA10
NOMESCO Finland
Bilateral
2.9
9.3
60
236
H47.2
ICD-10 Finland
Optic atrophy
37.8
9.1
11
*
C09CA06
ATC
candesartan; oral
2.8
9.0
64
265
J01FF01
ATC
clindamycin; systemic
2.4
9.0
88
437
SPAT1153
SPAT
Removal of sutures
2.3
8.7
96
504
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.7
8.6
63
268
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
28.4
8.5
11
*
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
28.4
8.5
11
*
H53.2
ICD-10 Finland
Diplopia
8.2
8.5
18
23
G43.9
ICD-10 Finland
Migraine, unspecified
3.3
8.4
43
145
G91.8
ICD-10 Finland
Other hydrocephalus
+∞
8.4
8
*
C08CA01
ATC
amlodipine; oral
2.7
8.3
61
258
M01AE02
ATC
naproxen; oral, rectal
2.0
8.1
205
1498
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.4
8.1
75
362
H02AB04
ATC
methylprednisolone; systemic
2.9
8.0
50
192
SPAT1249
SPAT
Treatment-related counselling outside office
2.0
8.0
160
1072
AAA27
NOMESCO Finland
Insertion of intracerebral pressure monitoring device
46.1
7.7
9
*
J45.9
ICD-10 Finland
Asthma, unspecified
2.6
7.7
60
262
M79.6
ICD-10 Finland
Pain in limb
2.1
7.7
113
667
Z3229
NOMESCO Finland
Other healthcare associate professional
4.1
7.7
29
76
R53
ICD-10 Finland
Malaise and fatigue
2.3
7.6
78
396
J35.1
ICD-10 Finland
Hypertrophy of tonsils
5.8
7.5
20
36
C09AA05
ATC
ramipril; oral
3.1
7.5
42
150
C09CA01
ATC
losartan; oral
2.9
7.4
46
175
N05CF01
ATC
zopiclone; oral
2.2
7.4
86
458
JDF11
NOMESCO Finland
Laparoscopic gastric bypass
6.5
7.3
18
29
AAF15
NOMESCO Finland
Ventriculoatrial shunt
+∞
7.3
7
*
N02AJ06
ATC
codeine and paracetamol; systemic
2.0
7.3
122
758
R01AD09
ATC
mometasone; nasal
1.9
7.2
170
1193
N06AX16
ATC
venlafaxine; oral
2.4
7.1
64
301
SPAT1260
SPAT
Consultation of another employee
2.4
7.1
64
301
KH1AD
NOMESCO Finland
CT of urinary organs
6.6
7.0
17
27
N06AX21
ATC
duloxetine; oral
2.8
7.0
47
187
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
5.3
6.9
20
40
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.8
6.9
44
172
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
8.5
6.9
14
17
H02AB09
ATC
hydrocortisone; systemic
6.3
6.9
17
28
R51
ICD-10 Finland
Headache
3.2
6.8
34
113
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.2
6.6
68
343
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.4
6.6
58
269
M03BX02
ATC
tizanidine; oral
1.8
6.6
196
1470
N06AX11
ATC
mirtazapine; oral
1.9
6.6
108
660
N20.1
ICD-10 Finland
Calculus of ureter
6.4
6.5
16
26
H93.1
ICD-10 Finland
Tinnitus
4.1
6.5
24
62
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
14.7
6.4
10
7
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.4
6.4
18
35
SPAT1310
SPAT
Counselling related to known health issue
1.9
6.4
121
775
C07AB07
ATC
bisoprolol; oral
2.0
6.3
86
488
C10AA05
ATC
atorvastatin; oral
2.4
6.3
55
256
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.7
6.3
41
163
G93.1
ICD-10 Finland
Anoxic brain damage, not elsewhere classified
+∞
6.3
6
*
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
+∞
6.3
6
*
G97.1
ICD-10 Finland
Other reaction to spinal and lumbar puncture
+∞
6.3
6
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
6.2
67
345
N05BA04
ATC
oxazepam; oral
2.0
6.1
84
476
N01
ICPC
Headache
2.2
6.1
66
340
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.6
6.1
45
192
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.0
6.0
92
544
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
6.0
107
668
N05AH04
ATC
quetiapine; oral
2.1
6.0
70
373
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
151
61
42.08
227.18
1.4
1.3
e6/l
184.9
28.7
1.44
134
50
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
151
61
42.08
227.18
1.4
1.2
e6/l
9.7
4.1
0.54
130
48
(3044290) Cell count panel - Cerebral spinal fluid
138
53
41.74
210.25
1.4
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
71
30
29.27
101.82
1.1
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
64
20
38.75
101.17
1.2
1.1
u/l
1.1
1.1
—
30
10
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
71
31
28.32
100.56
1.1
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
67
27
30.30
97.60
1.2
1.2
mg/l
51.2
30.8
0.41
57
21
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
68
29
28.71
97.05
1.1
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
62
25
29.79
90.10
1.1
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
57
25
26.93
80.09
1.3
1.2
—
—
—
0
0
(4027681)
54
23
27.47
76.62
1.3
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
58
32
21.44
74.03
1.5
1.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
127
243
7.55
68.94
2.4
1.9
nmol/l
378.7
384.8
0.10
120
223
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
32
14
25.00
44.38
1.3
1.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
182
685
4.37
42.21
4.5
4.9
inr
1.1
1.1
0.14
60
241
(3005719) IgG [Mass/volume] in Serum or Plasma
90
202
5.62
39.74
2.3
2.2
g/l
10.1
10.4
0.40
76
185
(3024561) Albumin [Mass/volume] in Serum or Plasma
206
876
4.18
39.66
5.6
4.7
g/l
37.0
37.2
0.18
198
825
(3002032) Base excess in Venous blood by calculation
78
158
6.03
38.42
5.1
4.2
mmol/l
-0.3
1.9
2.67
40
120
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
221
1017
4.07
37.29
7.8
6.2
mmol/l
1.2
1.2
0.90
186
867
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
202
903
3.84
34.94
9.3
6.0
mmol/l
1.2
1.2
0.17
191
832
(3013826) Glucose [Moles/volume] in Serum or Plasma
265
1431
4.28
34.31
6.9
4.5
mmol/l
6.2
6.3
0.13
254
1240
(3012544) pH of Venous blood
75
162
5.59
34.27
5.3
4.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
85
210
5.00
33.22
1.3
1.2
—
21.6
—
0
10
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
163
668
3.64
31.47
3.3
2.7
ng/l
18.7
19.4
0.05
64
259
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
146
565
3.67
30.66
2.5
1.9
u/l
116.5
300.2
0.93
141
538
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
57
106
6.21
30.38
1.7
1.9
u/l
39.2
40.4
0.16
51
95
(1616796) Gas panel - Central venous blood
34
40
9.29
27.08
3.4
1.8
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
95
305
3.88
25.84
4.0
3.7
mmol/l
0.8
0.8
1.65
90
289
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
20
11
19.20
24.90
1.1
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
21
13
17.10
24.75
1.0
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
74
216
4.06
22.83
5.9
4.1
—
—
—
0
0
(3009343) pH of Capillary blood
55
130
4.82
22.26
4.5
3.9
ph
7.4
7.4
0.71
12
12
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
54
126
4.87
22.19
4.5
3.9
mmol/l
-0.1
0.8
0.45
26
89
(3020891) Body temperature
35
54
7.08
22.16
6.0
4.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
58
144
4.61
22.10
10.4
10.7
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
68
197
4.03
21.12
7.9
7.3
mmol/l
107.0
104.9
3.49
68
191
(3015377) Calcium [Moles/volume] in Serum or Plasma
157
771
2.85
20.35
2.7
2.9
mmol/l
2.3
2.3
2.43
145
699
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
209
1191
2.81
20.29
5.7
5.4
umol/l
9.3
10.3
0.55
199
1129
(3019550) Sodium [Moles/volume] in Serum or Plasma
346
2782
8.27
16.29
21.3
9.1
mmol/l
139.9
139.5
4.43
346
2684
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
318
2422
3.80
15.77
5.5
4.2
pmol/l
14.3
14.3
0.03
303
2245
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
273
1912
2.80
15.76
7.8
6.2
u/l
75.7
71.4
1.00
267
1787
(3010421) pH of Blood
29
53
5.87
15.51
3.8
2.3
ph
7.4
7.4
2.56
24
48
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
83
333
2.94
15.11
1.3
1.3
iu/ml
85.0
169.9
1.46
31
137
(3003396) Base excess in Arterial blood by calculation
51
156
3.65
14.45
11.1
12.8
mmol/l
-0.0
0.9
0.72
27
116
(3021901) Oxygen saturation in Capillary blood
21
30
7.37
14.13
2.6
2.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
277
2017
2.65
13.66
4.4
3.4
mm/h
10.9
8.5
3.33
260
1878
(3018418) pH of Serum or Plasma
120
618
2.42
13.01
5.6
3.5
ph
7.4
7.4
1.97
33
109
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
162
956
2.27
12.73
3.6
2.9
u/l
25.0
27.6
0.78
151
919
(3012501) Base excess in Blood by calculation
25
48
5.52
12.67
3.9
2.1
mmol/l
1.7
2.5
—
10
31
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
185
1156
2.24
12.61
3.0
2.3
nmol/l
64.0
71.7
4.55
177
1076
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
297
2280
2.78
12.39
5.8
4.0
mmol/mol
37.4
37.4
0.03
286
2166
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
92
432
2.52
12.09
1.9
1.6
pmol/l
396.7
56010647.8
1.07
77
391
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
122
652
2.32
12.01
2.2
1.7
mg/l
0.7
0.8
0.22
85
460
(3044889) 12 lead EKG panel
229
1582
2.24
11.91
3.3
2.6
—
—
—
0
0
(3013512) EKG study
104
520
2.41
11.90
3.3
2.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
71
308
2.63
10.90
2.4
1.5
nmol/l
1282.6
1120.8
0.80
60
248
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
33
91
3.89
10.79
1.4
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
15
7
22.28
10.77
1.4
2.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
333
2789
3.78
10.56
6.4
4.7
mu/l
1.8
1.7
0.64
323
2632
(3019060) Gas panel - Arterial blood
30
79
4.05
10.44
8.1
10.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
83
398
2.41
10.28
2.7
2.2
u/l
4243.7
4763.0
0.09
27
176
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
14
18
8.05
10.21
1.4
1.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
316
2588
2.88
10.06
4.8
3.1
mmol/l
5.8
5.6
1.76
299
2401
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
13
9.52
9.92
1.0
1.0
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
128
745
2.12
9.88
5.3
2.4
u/l
47.7
54.1
2.43
122
693
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
43
151
3.10
9.72
5.4
2.9
mmol/l
1.2
1.2
0.07
38
128
(3006315) Basophils [#/volume] in Blood
204
1425
2.00
9.35
7.1
5.4
e9/l
0.0
0.0
0.65
188
1260
(3001604) Monocytes [#/volume] in Blood
203
1417
2.00
9.31
7.2
5.3
e9/l
0.5
0.5
0.27
188
1255
(3019198) Lymphocytes [#/volume] in Blood
211
1495
2.00
9.24
7.2
5.3
e9/l
2.0
2.0
0.05
197
1357
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
117
675
2.09
9.12
2.5
2.0
mg/l
3.3
2.7
1.30
108
583
(3026493) Urate [Moles/volume] in Serum or Plasma
99
536
2.17
9.10
2.8
2.4
umol/l
323.3
3612.1
1.57
89
486
(3035637) Corticotropin [Mass/volume] in Plasma
16
28
5.93
8.88
1.5
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
90
476
2.19
8.74
4.0
3.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
129
782
2.02
8.72
4.9
3.3
estimate
0.0
0.0
0.80
58
311
(3013650) Neutrophils [#/volume] in Blood by Automated count
224
1641
1.98
8.68
8.9
8.0
e9/l
4.6
3.9
4.48
210
1429
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
22
53
4.36
8.58
3.9
5.2
%
60.6
58.5
0.34
22
53
(3013115) Eosinophils [#/volume] in Blood
207
1480
1.95
8.58
7.4
5.7
e9/l
0.2
0.2
0.93
192
1328
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
24
62
4.08
8.57
1.6
2.1
mg/l
11.3
10.8
0.12
24
55
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
172
1158
1.93
8.52
4.6
3.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
134
829
1.99
8.51
3.7
2.2
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
29
87
3.54
8.40
17.0
13.4
%
94.8
94.5
0.12
29
87
(3025159) Blasts/100 leukocytes in Blood
42
162
2.80
8.03
5.4
4.4
%
0.0
0.0
—
10
33
(42870588) Differential panel, method unspecified - Blood
136
860
1.94
8.00
7.4
5.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
66
319
2.31
7.90
1.9
1.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
132
831
1.93
7.84
4.9
3.0
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
12
8
15.46
7.76
1.0
1.0
mg/g
25.0
5.0
—
12
8
(40761511) CBC panel - Blood by Automated count
350
3214
4.98
7.64
18.3
8.8
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
253
1979
1.95
7.54
5.7
3.9
e6/l
2103.8
636.8
—
5
23
(3035350) Ketones [Presence] in Urine by Test strip
201
1462
1.85
7.51
4.4
3.1
estimate
0.0
0.0
0.50
59
307
(3037522) Nuclear Ab [Titer] in Serum
81
435
2.11
7.47
1.3
1.4
titre
420.0
483.3
0.14
14
86
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
12
9
13.74
7.43
1.0
1.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
68
345
2.20
7.22
2.6
2.3
mmol/l
2.4
2.4
0.02
60
303
(3021960) Folate [Moles/volume] in Serum or Plasma
86
479
2.05
7.17
1.7
1.3
nmol/l
19.1
20.8
0.49
74
423
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
10
5
20.51
7.17
1.1
1.6
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
10
5
20.51
7.17
1.1
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
10
5
20.51
7.17
1.2
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
5
20.51
7.17
1.1
1.4
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
10
5
20.51
7.17
1.2
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
133
860
1.87
7.15
2.2
1.7
pmol/l
100.3
95.1
0.69
92
478
(3004789) Transferrin [Mass/volume] in Serum or Plasma
63
312
2.24
7.09
3.5
2.2
g/l
2.4
2.5
0.64
55
285
(3030905) Polymorphonuclear cells [#/volume] in Blood
20
52
4.01
7.08
3.5
4.7
e9/l
4.0
4.7
0.66
20
52
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
15
31
5.01
6.99
1.8
2.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
199
1465
1.81
6.94
5.7
4.3
estimate
0.0
0.0
0.50
58
315
(3017181) Myelocytes/100 leukocytes in Blood
43
181
2.56
6.93
5.5
4.1
%
0.6
0.7
—
10
46
(3026782) Osmolality of Urine
84
470
2.03
6.90
5.0
2.5
mosm/kgh2o
534.0
576.5
0.99
74
398
(3009508) Creatinine [Moles/volume] in Urine
105
636
1.92
6.86
3.1
3.2
mmol/l
7.2
8.4
1.61
95
552
(3002179) Metamyelocytes/100 leukocytes in Blood
40
164
2.62
6.80
4.5
3.9
%
0.7
0.5
—
9
28
(3000850) Epithelial cells [#/volume] in Urine
89
511
1.99
6.79
4.3
2.5
e6/l
6.8
8.6
0.79
83
436
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
56
269
2.28
6.77
3.7
2.3
%
22.4
24.6
0.60
41
231
(3021440) Promyelocytes/100 leukocytes in Blood
41
171
2.58
6.73
4.8
4.2
%
0.0
0.1
—
10
39
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
10
14
7.32
6.73
1.1
1.7
—
—
—
0
0
(3015736) pH of Urine
164
1149
1.79
6.68
3.7
2.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
258
2074
1.87
6.54
5.2
3.8
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
177
1278
1.76
6.42
7.3
5.5
%
0.6
0.7
1.45
172
1194
(3022313) Gas panel - Capillary blood
28
98
3.01
6.36
6.1
3.9
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
199
1489
1.76
6.34
4.5
3.1
estimate
0.0
0.0
0.00
59
305
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
15
34
4.56
6.29
6.5
2.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
336
3000
2.95
6.16
18.9
9.6
mg/l
13.4
19.2
7.35
298
2252
(3020682) Albumin/Creatinine [Ratio] in Urine
82
472
1.96
6.16
4.9
4.6
mg/mmol
24.1
12.4
0.37
49
319
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
10
8
12.81
6.11
1.0
1.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
289
0.19
6.11
1.3
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
79
454
1.95
5.95
3.5
3.7
mg/l
997.3
236.9
0.38
49
310
(3019225) pH of Specimen
41
182
2.41
5.91
2.3
3.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
83
487
1.92
5.87
2.3
2.6
ug/g
125.3
85.3
0.28
67
370
(3029634) Reagin Ab [Titer] in Serum by VDRL
19
55
3.59
5.81
1.3
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
294
0.22
5.74
1.3
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
288
0.23
5.59
1.3
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
38
168
2.41
5.53
3.2
2.9
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
48
235
2.20
5.53
1.6
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
18
52
3.59
5.52
1.9
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
19
57
3.46
5.52
1.6
1.4
ug/g
273.3
328.0
0.41
11
29
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
255
2090
1.76
5.51
3.8
2.7
u/l
35.3
31.5
0.78
243
2007
(3022948) Iron [Moles/volume] in Serum or Plasma
63
343
2.02
5.51
3.6
2.2
umol/l
13.2
14.5
0.80
53
311
(3018010) Neutrophils/100 leukocytes in Blood
186
1402
1.68
5.48
7.7
5.1
%
60.0
56.2
6.03
181
1328
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
44
209
2.26
5.45
3.4
2.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
27
102
2.78
5.37
1.2
1.2
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
35
151
2.46
5.37
11.6
8.7
mmol/l
8.2
7.0
0.47
35
145
(3004809) Band form neutrophils/100 leukocytes in Blood
13
30
4.46
5.34
2.2
2.8
%
1.8
1.7
0.04
13
22
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
57
303
2.05
5.32
1.8
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
62
340
2.00
5.31
4.2
3.1
ng/l
1507.7
764.1
0.39
42
256
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
86
527
1.83
5.28
1.4
1.3
iu/ml
13.5
20.5
0.99
20
155
(3002582) Erythrocytes [#/volume] in Urine
110
730
1.73
5.13
5.4
2.8
e6/l
67.8
183.0
0.55
93
540
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
13
31
4.31
5.13
1.2
1.2
nmol/l
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
13
31
4.31
5.13
1.2
1.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
102
663
1.75
5.12
4.5
2.7
e6/l
0.1
0.3
1.27
90
488
(3006653) Thiamine [Moles/volume] in Blood
9
9
10.22
5.05
1.7
1.8
nmol/l
124.6
125.9
—
9
9
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
23
83
2.89
4.98
13.7
18.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
111
747
1.70
4.89
6.5
4.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
300
2615
1.91
4.89
13.8
7.8
ml/min/173m2
94.9
97.2
0.96
269
2021
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
12
28
4.40
4.86
1.1
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
98
639
1.73
4.84
4.3
3.1
kg/l
1.0
1.0
0.28
13
87
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
10
20
5.11
4.80
1.1
1.1
miu/ml
1508.4
1450.7
—
10
20
(3023520) Reticulocytes [#/volume] in Blood
27
109
2.60
4.75
3.2
2.5
e9/l
78.9
77.1
0.08
18
82
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
26
104
2.62
4.66
1.3
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
11
25
4.51
4.59
1.4
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
40
198
2.15
4.49
1.2
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
293
2557
1.80
4.46
4.0
2.9
mmol/l
1.4
1.2
7.26
278
2415
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
11
26
4.33
4.38
1.2
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
11
26
4.33
4.38
2.5
1.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
100
673
1.67
4.34
4.6
2.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
303
2679
1.85
4.31
4.3
3.1
mmol/l
1.3
1.5
18.79
290
2541
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
16
51
3.24
4.26
9.8
2.2
nmol/l
1.3
1.0
0.72
16
45
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
306
2718
1.87
4.23
4.5
3.3
mmol/l
2.9
2.8
0.57
289
2567
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
44
233
2.01
4.14
3.6
3.7
pmol/l
4.7
4.7
0.02
35
210
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
22
87
2.63
4.05
2.8
2.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
50
280
1.91
4.02
1.4
1.4
iu/l
12.0
18.2
1.27
45
237
(40761536) Microorganisms panel - Urine sediment
51
288
1.90
4.00
5.7
3.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
123
889
1.58
3.96
1.4
1.3
u/ml
2.6
1.8
0.17
33
241
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
14
43
3.35
3.95
1.0
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
59
351
1.82
3.93
4.2
2.6
ng/l
27.7
322.4
2.50
27
168
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
8
11
7.41
3.88
1.0
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
15
384
0.36
3.87
1.4
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
54
317
1.83
3.76
1.2
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
20
80
2.59
3.61
2.8
3.1
g/l
0.1
0.4
—
7
37
(3041096) Erythrocytes [Presence] in Urine by Automated
123
907
1.54
3.57
4.3
2.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
15
52
2.97
3.50
1.1
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
28
133
2.20
3.50
1.3
1.6
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
14
48
2.99
3.33
1.1
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
125
937
1.51
3.32
6.2
3.3
e6/l
27.8
54.9
1.44
100
591
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
299
2692
1.67
3.25
4.4
3.2
mmol/l
4.6
4.7
1.73
285
2557
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
178
1438
1.47
3.25
4.7
4.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
10
28
3.65
3.22
1.2
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
37
203
1.92
3.17
1.9
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
35
189
1.94
3.14
1.1
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
44
258
1.80
3.08
1.3
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
77
526
1.59
3.07
1.2
1.3
u/ml
1.2
8.4
3.19
23
221
(36660697) Celiac disease serology panel - Serum
50
306
1.74
3.03
1.2
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
18
76
2.44
2.94
2.2
1.8
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
40
649
0.57
2.91
1.4
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
34
187
1.90
2.91
1.4
1.4
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
12
42
2.92
2.77
1.0
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
17
358
0.45
2.76
1.5
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
56
363
1.64
2.76
2.9
2.3
e6/l
0.8
0.8
0.04
38
198
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
17
73
2.40
2.69
1.2
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
19
4.28
2.69
2.4
2.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
24
120
2.07
2.68
1.9
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
49
311
1.67
2.62
2.1
2.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
14
56
2.56
2.56
1.1
1.1
iu/ml
1.0
15.5
—
7
20
(3042733) HLA Ab [Presence] in Serum
5
7
7.22
2.55
3.2
3.1
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
6
11
5.53
2.55
1.5
2.3
ug/l
1.0
1.7
—
6
11
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
18
359
0.47
2.53
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
18
359
0.47
2.53
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
18
359
0.47
2.53
1.4
1.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
21
102
2.12
2.53
6.5
3.0
e6/l
0.1
0.1
0.03
21
97
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
29
159
1.90
2.52
1.7
2.0
ml/min/173m2
59.6
83.3
1.58
12
59
(3011397) Hemoglobin [Presence] in Urine by Test strip
87
637
1.48
2.51
3.8
3.0
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
36
212
1.78
2.51
1.3
1.3
u/ml
858.5
155.5
0.50
31
195
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
70
490
1.53
2.50
2.1
2.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
17
76
2.30
2.48
1.2
2.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
34
199
1.78
2.42
1.9
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
9
27
3.39
2.41
1.4
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
102
777
1.44
2.39
1.6
1.4
g/l
2.0
2.1
0.49
69
482
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
18
85
2.18
2.33
1.6
1.3
u/ml
184.4
208.8
0.20
13
57
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
13
53
2.51
2.30
1.4
1.4
—
1.7
—
0
5
(3051387) C reactive protein [Mass/volume] in Capillary blood
14
60
2.39
2.24
3.8
3.6
mg/l
14.3
27.5
—
9
42
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
164
0.36
2.21
1.2
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
199
1713
1.36
2.21
4.3
2.9
ug/l
77.9
61.5
1.39
188
1606
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
8
24
3.38
2.19
1.1
1.3
—
—
—
0
0
(3036489) Thrombin time
22
116
1.96
2.16
2.2
1.7
s
20.8
20.5
0.20
16
100
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
14
4.34
2.16
1.0
1.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
30
177
1.76
2.10
1.7
1.3
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
10
5.05
2.07
1.0
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
155
1294
1.35
2.05
11.7
7.4
e9/l
0.0
0.0
0.53
140
1050
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
38
2.68
2.02
1.1
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
114
909
1.37
2.02
2.5
1.9
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
13
57
2.33
2.00
1.2
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
43
284
1.58
1.99
3.1
2.9
umol/l
5.0
5.2
0.11
35
227
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
11
4.59
1.94
1.2
3.2
u/ml
375.4
382.6
—
5
11
(3025468) Yersinia sp identified in Specimen by Organism specific culture
9
33
2.77
1.94
1.2
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
16
3.79
1.94
1.0
1.0
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
19
99
1.97
1.94
1.1
1.1
u/ml
3.3
6.1
—
7
56
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
21
114
1.89
1.91
1.2
1.1
u/ml
1.9
1.8
—
7
43
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
38
246
1.61
1.91
3.9
3.0
%
28.3
31.4
1.35
32
178
(3020961) Endomysium IgA Ab [Titer] in Serum
33
206
1.66
1.91
1.2
1.1
—
134.0
—
0
5
(3023430) Cat dander IgE Ab [Units/volume] in Serum
15
72
2.13
1.89
1.1
1.1
u/ml
5.0
6.3
—
6
25
(3014148) Varicella zoster virus Ab [Titer] in Serum
15
72
2.13
1.89
1.2
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
34
2.69
1.87
1.2
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
34
2.69
1.87
1.2
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
34
2.69
1.87
1.2
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
34
2.69
1.87
1.2
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
34
2.69
1.87
1.2
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
11
46
2.44
1.87
3.9
2.8
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
11
46
2.44
1.87
1.2
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
59
2.25
1.86
1.2
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
5
12
4.21
1.83
2.4
1.8
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
9
35
2.61
1.81
5.8
2.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
31
474
0.62
1.77
1.3
1.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
18
3.37
1.75
1.2
1.3
pg
33.7
33.1
—
6
18
(43055514) Macroprolactin [Presence] in Serum or Plasma
6
18
3.37
1.75
1.3
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
30
2.70
1.73
1.6
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
30
2.70
1.73
1.6
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
17
89
1.96
1.73
1.5
1.3
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
13
3.88
1.72
1.2
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
13
3.88
1.72
1.2
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
13
3.88
1.72
1.6
1.5
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
16
83
1.97
1.67
1.1
1.0
u/ml
8.5
6.1
—
5
26
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
14
3.61
1.62
1.0
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
14
3.61
1.62
7.2
2.7
%
12.3
11.7
—
5
14
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
8
32
2.53
1.60
1.0
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
10
44
2.31
1.54
1.8
1.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
48
345
1.45
1.53
4.4
2.5
e6/l
2.9
4.1
0.62
29
181
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
44
0.00
1.52
0.0
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
27
2.62
1.52
1.3
1.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
27
2.62
1.52
1.0
1.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
86
686
1.33
1.49
2.4
1.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
129
1089
1.29
1.48
2.2
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
37
254
1.51
1.48
1.0
1.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
25
383
0.63
1.46
1.4
1.4
—
—
—
0
0
(4198724)
5
16
3.15
1.44
1.6
2.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
5
16
3.15
1.44
1.0
1.2
—
—
—
0
0
(4035726)
25
158
1.63
1.42
1.4
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
33
224
1.52
1.39
4.4
2.1
e9/l
5.7
4.1
1.19
27
197
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
23
2.64
1.37
1.2
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
17
2.97
1.36
2.4
2.8
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
38
0.00
1.35
0.0
1.3
—
—
—
0
0
(4010399)
22
139
1.62
1.26
1.4
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
25
2.42
1.25
1.0
1.5
—
—
—
0
0
(4062490)
6
26
2.33
1.19
4.3
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
83
681
1.28
1.17
4.5
5.7
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
13
72
1.84
1.16
1.0
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
33
234
1.45
1.16
1.4
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
16
95
1.72
1.15
1.3
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
16
95
1.72
1.15
1.3
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
10
51
1.99
1.12
1.7
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
39
288
1.40
1.11
1.4
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
21
137
1.57
1.08
1.6
1.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
57
451
1.31
1.06
2.3
1.8
%
1.3
1.3
0.34
50
417
(1002224) Polysomnography panel
21
138
1.55
1.05
1.2
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
39
291
1.38
1.05
1.4
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
78
645
1.27
1.04
2.0
1.6
mmol/l
1.5
1.4
1.01
69
571
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
34
2.08
1.03
1.6
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
47
1.94
1.03
1.1
1.8
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
16
99
1.64
1.01
1.3
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
54
1.88
0.97
1.4
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
0
31
0.00
0.97
0.0
1.6
—
8877.6
—
0
20
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
14
85
1.67
0.95
2.1
2.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
36
270
1.37
0.95
1.4
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
38
288
1.36
0.94
1.4
1.5
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
6
27
2.24
0.94
1.2
15.8
mmol/l
24.6
6.2
—
6
20
(44790049)
6
27
2.24
0.94
1.3
1.3
—
—
—
0
0
(44806118)
6
27
2.24
0.94
1.3
1.3
—
—
—
0
0
(44790048)
6
27
2.24
0.94
1.3
1.3
—
—
—
0
0
(44790047)
6
27
2.24
0.94
1.3
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
19
126
1.54
0.93
1.5
1.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
52
1.75
0.93
1.8
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
38
289
1.35
0.93
1.4
1.5
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
12
71
1.71
0.90
1.2
1.1
—
11.0
—
0
7
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
29
2.09
0.89
1.2
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
28
204
1.40
0.88
1.4
1.9
—
—
—
0
0
(4268621)
8
43
1.88
0.88
1.9
2.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
70
585
1.24
0.86
1.9
1.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
140
0.56
0.85
1.6
1.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
10
57
1.78
0.84
1.1
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
10
57
1.78
0.84
1.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
11
66
1.69
0.79
1.7
2.4
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
28
0.00
0.76
0.0
3.6
—
—
—
0
0
(4306422)
9
54
1.68
0.75
1.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
38
1.86
0.74
1.0
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
39
1.81
0.73
1.3
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
7
39
1.81
0.73
1.4
1.8
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
11
68
1.64
0.72
2.3
2.8
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
41
1.72
0.70
1.3
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
124
1118
1.17
0.69
1.9
1.9
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
27
1.86
0.68
1.0
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
13
86
1.53
0.67
1.5
1.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
10
153
0.64
0.64
1.1
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
13
88
1.50
0.61
1.1
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
21
0.00
0.60
0.0
1.9
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
21
275
0.75
0.59
1.5
1.7
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
24
307
0.77
0.58
1.4
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
35
1.73
0.58
1.0
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
13
90
1.46
0.56
1.1
1.1
—
—
—
0
0
(4034850)
13
90
1.46
0.56
15.5
7.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
10
65
1.55
0.56
1.1
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
37
1.63
0.56
1.2
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
28
225
1.27
0.51
1.3
1.3
miu/ml
240.8
271.7
—
10
120
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
22
278
0.78
0.50
1.2
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
38
319
1.21
0.48
1.1
1.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
8
59
1.36
0.41
1.4
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
91
991
0.89
0.40
1.8
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
7
103
0.67
0.40
1.1
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
8
61
1.32
0.40
2.6
3.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
32
272
1.19
0.37
1.4
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
19
234
0.80
0.37
1.3
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
14
108
1.31
0.36
4.1
2.3
—
—
—
0
0
(4094501)
6
43
1.40
0.35
1.2
1.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
6
45
1.34
0.34
1.8
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
47
1.28
0.32
1.0
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
47
1.28
0.32
1.0
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
14
110
1.28
0.32
1.3
1.6
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
7
52
1.35
0.31
1.0
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
7
99
0.70
0.31
2.1
1.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
34
298
1.16
0.29
1.5
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
15
184
0.81
0.29
1.3
1.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
8
110
0.72
0.29
1.5
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
38
424
0.88
0.26
1.5
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
128
1342
0.93
0.25
2.1
2.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
103
974
1.08
0.25
2.3
2.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
10
80
1.26
0.20
1.6
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
38
348
1.10
0.18
1.6
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
33
300
1.11
0.18
2.3
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
11
91
1.22
0.17
1.5
1.9
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
18
158
1.15
0.16
2.9
3.8
%
29.2
22.2
—
5
64
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
58
546
1.07
0.16
1.8
1.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
73
698
1.06
0.13
2.1
2.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
15
132
1.14
0.13
1.7
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
280
2767
1.05
0.13
4.3
4.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
15
168
0.89
0.12
4.7
2.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
46
1.09
0.09
1.2
1.0
—
—
—
0
0
(3000492) Spirometry study
28
263
1.07
0.08
1.1
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
66
638
1.04
0.08
1.7
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
109
1114
0.97
0.08
1.8
1.8
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
7
81
0.86
0.07
1.1
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
81
0.86
0.07
1.1
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
7
81
0.86
0.07
1.3
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
302
3002
1.04
0.06
17.4
10.5
%
39.4
40.0
0.53
215
2544
(3034274) Bile acid [Moles/volume] in Serum --fasting
13
141
0.92
0.05
2.1
2.3
umol/l
3.6
4.8
—
8
104
(3003694) ABO and Rh group [Type] in Blood
122
1203
1.02
0.04
1.7
1.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
28
290
0.96
0.03
2.0
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
20
198
1.01
0.00
1.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
17
171
0.99
0.00
2.6
2.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
113
1128
1.00
0.00
2.9
2.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
107
1069
1.00
0.00
2.5
2.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
12
123
0.97
0.00
2.3
2.5
ug/l
0.7
0.6
—
6
69
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
93
927
1.00
0.00
1.4
1.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
50
1.00
0.00
1.2
1.5
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
9
0.00
0.00
0.0
5.6
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
29.7
—
0
5
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
6
0.00
0.00
0.0
9.2
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
16.6
—
0
5
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(4133840)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
57
0.88
0.00
1.0
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
6
60
1.00
0.00
12.8
1.8
%
13.0
13.1
—
6
60
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
174.6
—
0
5
(3036048) Francisella tularensis Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
0.0
—
0
6
(3017569) Oxygen content in Arterial blood
0
7
0.00
0.00
0.0
11.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
9
0.00
0.00
0.0
2.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
96
0.94
0.00
1.9
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
9
0.00
0.00
0.0
2.8
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_BENINTRAHYP and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have G6_BENINTRAHYP.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: G6_BENINTRAHYP – Benign intracranial hypertension
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data